| Literature DB >> 22830978 |
Luciano de Sousa Chaves1, Lucas Antonio Duarte Nicolau, Renan Oliveira Silva, Francisco Clark Nogueira Barros, Ana Lúcia Ponte Freitas, Karoline Sabóia Aragão, Ronaldo de Albuquerque Ribeiro, Marcellus Henrique Loiola Ponte Souza, André Luiz dos Reis Barbosa, Jand-Venes Rolim Medeiros.
Abstract
Many algal species contain relatively high concentrations of polysaccharide substances, a number of which have been shown to have anti-inflammatory and/or immunomodulatory activity. In this study, we evaluated the anti-inflammatory and antinociceptive effects in mice of a sulfated polysaccharide fraction (PLS) extracted from the algae Gracilaria caudata. The antiinflammatory activity of PLS was evaluated using several inflammatory agents (carrageenan, dextran, bradykinin, and histamine) to induce paw edema and peritonitis in Swiss mice. Samples of the paw tissue and peritoneal fluid were removed to determine myeloperoxidase (MPO) activity or TNF-α and IL-1β levels, respectively. Mechanical hypernociception was induced by subcutaneous injection of carrageenan into the plantar surface of the paw. Pretreatment of mice by intraperitoneal administration of PLS (2.5, 5, and 10 mg/kg) significantly and dose-dependently reduced carrageenan-induced paw edema (p < 0.05) compared to vehicle-treated mice. Similarly, PLS 10 mg/kg effectively inhibited edema induced by dextran and histamine; however, edema induced by bradykinin was unaffected by PLS. PLS 10 mg/kg inhibited total and differential peritoneal leukocyte counts following carrageenan-induced peritonitis. Furthermore, PLS reduced carrageenan-increased MPO activity in paws and reduced cytokine levels in the peritoneal cavity. Finally PLS pretreatment also reduced hypernociception 3-4 h after carrageenan. We conclude that PLS reduces the inflammatory response and hypernociception in mice by reducing neutrophil migration and cytokines concentration.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22830978 DOI: 10.3109/08923973.2012.707211
Source DB: PubMed Journal: Immunopharmacol Immunotoxicol ISSN: 0892-3973 Impact factor: 2.730